Find uplifting stories about heroes, innovations, and solutions
48 results for "tuberculosis"
Scientists in South Africa are on the brink of developing the world's first effective tuberculosis vaccine for adolescents and adults, a breakthrough that could prevent 76 million infections globally. African leaders visited the groundbreaking research site and called for urgent investment to prepare the continent for mass vaccine rollout.
South Carolina just made it faster to hire nursing home workers without sacrificing resident safety. The new law modernizes tuberculosis testing rules that previously delayed qualified caregivers from starting work for up to two weeks.
%2Ffile%2Fattachments%2Forphans%2FProfessorWillemHanekom_276321.jpeg)
Professor Willem Hanekom is co-leading a 20,000-person global trial for the world's most promising TB vaccine while directing Africa's largest health research institute. Living openly with HIV for 19 years, he's dedicated his career to bringing life-saving treatments to underresourced communities.
A teacher fired for taking a military exam became the founder of Lupin, now the world's largest tuberculosis medicine maker. Desh Bandhu Gupta's journey from childhood hardship to building a pharmaceutical empire shows how one setback sparked a revolution in affordable healthcare.
Researchers in Melbourne have discovered a hidden "on switch" in tuberculosis bacteria that could lead to treatments for drug-resistant strains. The breakthrough uses advanced imaging to target the disease in a completely new way.
A groundbreaking tuberculosis test using simple tongue swabs is bringing hope to millions. At just $3 per test, it's faster, cheaper, and more accurate than methods used for 150 years.
Village health workers in Uganda now carry AI-powered tools that screen for tuberculosis in four local languages, bringing life-saving diagnosis to remote communities. The innovation is already closing gaps in a country where 8,000 TB cases go undetected each year.
A Saskatchewan team has developed a groundbreaking vaccine that protects cattle from tuberculosis without interfering with disease testing. If approved, MSX-1 would be the world's first licensed bovine TB vaccine.
A hospital in Angola reduced tuberculosis treatment abandonment by nearly 20% through home visits and family support programs. The progress shows how community-based care can help patients complete life-saving treatment.
When US funding cuts threatened to collapse decades of life-saving health research in South Africa, the country fought back with a $32 million rescue package. Now 59 critical HIV and tuberculosis research projects are moving forward.
A University of Saskatchewan team has developed a groundbreaking vaccine that protects cattle from tuberculosis without interfering with disease testing. The breakthrough could save thousands of farms from devastating herd losses.
Indian researchers have validated two groundbreaking tuberculosis vaccines that show up to 79.5% effectiveness against the disease, offering new hope for children and adults in a country carrying 27% of the world's TB burden. The vaccines demonstrate particular promise in protecting kids aged 6 to 14 from all forms of TB.
Scientists at Johns Hopkins developed a nose-delivered vaccine that helps the body fight tuberculosis, the world's deadliest infectious disease. Early tests show it could shorten treatment times and prevent drug-resistant strains.
Europe commits over €3 billion to the Global Fund, staying at the forefront of efforts to eliminate three of the world's deadliest diseases. The investment will save millions of lives in countries hit hardest by malaria, tuberculosis, and HIV. #
When Barry Bloom got pancreatic cancer, he became a research participant and studied his own treatment papers with the same curiosity that defined his 60-year career. The legendary Harvard immunologist who discovered how our immune system remembers past infections died at 88, leaving behind breakthrough discoveries that transformed how we fight diseases like tuberculosis and leprosy.
Nigeria's capital territory is winning the fight against tuberculosis with a remarkable 94% treatment success rate and a 64% drop in TB deaths. Despite reporting 16,000 cases annually, early detection and community outreach are turning the tide on this deadly disease.
Nigeria has cut tuberculosis deaths by 63% since 2015, proving that sustained public health efforts can transform even the oldest diseases into beatable challenges. With a 94% treatment success rate, the country is showing Africa what's possible when communities, government, and health partners work together.
Nigeria's Federal Capital Territory is saving lives at an unprecedented rate, curing 94% of tuberculosis patients through early detection and community care. TB deaths have dropped 64% as health workers bring free screening directly to neighborhoods.
Despite devastating conflict, a new $1.6 million emergency fund is bringing life-saving tuberculosis care to millions of displaced people in Sudan. The program will reach communities in 10 states through mobile clinics and community-based services.
Scientists in South Africa are leading a breakthrough tuberculosis vaccine trial that could protect adolescents and adults for the first time in over a century. The M72 vaccine, combined with faster tests and shorter treatments, marks a turning point against the world's deadliest infectious disease.
Showing 20 of 48